[Corrigendum] Survival outcomes in patients with T3‑4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy
- Authors:
- Published online on: May 15, 2024 https://doi.org/10.3892/ol.2024.14456
- Article Number: 323
-
Copyright : © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article
Oncol Lett 24: [Related article:] 434, 2022; DOI: 10.3892/ol.2022.13554
Following the publication of this article, the authors have realized that an incorrect description of the treatment protocol was reported in the “Postoperative procedures” subsection of the “Materials and methods” on p. 2 concerning the three regimens on which platinum-based chemoradiotherapy (CRT) was based. The sentence commencing on line 15 of this section should have read as follows (changes are highlighted in bold): “[Platinum-based concurrent CRT was performed based on one of three regimens: i) cisplatin (DDP) regimen-DDP [75 mg/m2 (not “45–50 mg/m2/day”)] on days 1–3; ii) DDP combined with 5-fluorouracil (5-FU) (PF regimen)-DDP [75 mg/m2 (not “40 mg/m2/day”)] on days 1–3 and 5-FU [650–700 mg/m2 (not 750–800 mg/m2/day)] on days 1–4 (not days 1–5); or iii) carboplatin (CBP) regimen-CBP (AUC=5) on days 1–2 [not, as was reported, “carboplatin (CBP)-based regimen-CBP, calcium folinate, and tegafur (200, 300, or 1,000 mg/m2/day, respectively) on days 1–3 for 1–2 cycles].
The authors regret that this misinformation was reported in the text, and thank the Editor of Oncology Letters for allowing them the opportunity to publish this Corrigendum.
